ヘルスケア株
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2805 |  TCMD Tactile Systems Technology, Inc. - Common Stock | 23.29 USD | +3.93% | +5.58% | +3.83% | +59.96% | 527.57 M USD | ||
| 2806 |  CTMX CytomX Therapeutics, Inc. - Common Stock | 2.41 USD | +8.07% | -2.03% | -14.84% | -26.52% | 525.14 M USD | ||
| 2809 |  SSII SS Innovations International Inc. - Common Stock | 2.60 USD | -3.70% | -1.89% | -21.21% | -69.66% | 521.00 M USD | ||
| 2817 |  DCTH Delcath Systems, Inc. - Common Stock | 14.81 USD | +0.61% | -1.73% | -10.08% | +43.23% | 513.89 M USD | ||
| 2819 |  ACRS Aclaris Therapeutics, Inc. - Common Stock | 3.49 USD | +3.25% | -7.18% | -35.01% | +73.63% | 513.72 M USD | ||
| 2821 |  VALN Valneva SE - American Depositary Shares | 5.91 USD | +4.42% | +1.72% | -9.91% | -41.83% | 512.81 M USD | ||
| 2824 |  AQST Aquestive Therapeutics, Inc. - Common Stock | 4.06 USD | -11.93% | -15.06% | -18.80% | -41.24% | 509.58 M USD | ||
| 2827 |  SGMT Sagimet Biosciences Inc. - Series A Common Stock | 8.17 USD | +8.21% | -7.58% | -23.57% | +10.26% | 507.84 M USD | ||
| 2832 |  EVO Evotec SE - American Depositary Shares each representing 1/2 of | 1.42 USD | -0.70% | -8.97% | -12.35% | -66.74% | 504.89 M USD | ||
| 2839 |  EOLS Evolus, Inc. - Common Stock | 7.57 USD | +4.85% | -2.57% | -6.66% | +21.51% | 500.00 M USD | ||
| 2840 |  SOPH SOPHiA GENETICS SA - Ordinary Shares | 7.29 USD | +3.26% | -0.41% | -11.10% | +69.14% | 499.27 M USD | ||
| 2850 |  MASS 908 Devices Inc. - Common Stock | 11.89 USD | +0.51% | +2.59% | +17.14% | +38.74% | 491.46 M USD | ||
| 2856 |  ANGO AngioDynamics, Inc. - Common Stock | 11.58 USD | +4.80% | +4.70% | -25.53% | -6.46% | 486.99 M USD | ||
| 2859 |  SGHT Sight Sciences, Inc. - Common Stock | 8.80 USD | +6.67% | +4.27% | +5.77% | +125.64% | 484.77 M USD | ||
| 2862 |  MNPR Monopar Therapeutics Inc. - Common Stock | 71.80 USD | -1.78% | -13.98% | -30.51% | +31.45% | 481.93 M USD | ||
| 2868 |  ENTX Entera Bio Ltd. - Ordinary Shares | 2.77 USD | +10.80% | +10.36% | -6.10% | +14.46% | 479.60 M USD | ||
| 2870 |  NGNE Neurogene Inc. - Common Stock | 23.95 USD | +7.98% | -17.13% | -32.27% | -18.59% | 479.27 M USD | ||
| 2871 |  YDES YD Bio Limited - Ordinary Shares | 6.74 USD | +5.97% | +18.04% | +82.16% | -63.96% | 477.12 M USD | ||
| 2875 |  NNNN Anbio Biotechnology - Class A Ordinary Shares | 3.30 USD | -7.56% | -27.47% | -39.23% | -87.52% | 474.84 M USD | ||
| 2877 |  TLRY Tilray Brands, Inc. - Common Stock | 3.21 USD | +2.23% | -10.83% | -19.95% | +114.00% | 474.40 M USD |
ニュース ヘルスケア株
MacroGenics、進行固形腫瘍患者を対象とした、非開示標的に向けた抗体薬物複合体MGC030の第1相試験で最初の患者への投与を開始
木曜日の取引中に動いたヘルスケア株12銘柄
Dyadic Internationalの13G提出書類は、Empery Asset Managementが9月30日時点で同社株式8.35%を保有していると報告していることを示す
NeurAxis、医療ポリシーの適用対象が2,600万人超の医療保険加入者に拡大したと発表
Edesa Biotech、尋常性白斑におけるEB06の第2相臨床試験に関する治験薬（IND）申請についてFDAの承認を取得
Wedbush、Sutro Biopharmaの「アウトパフォーム」を再確認、目標株価60ドルを維持
ゼネティック・バイオサイエンシズ、提携先のPeriNessがイスラエルで大細胞B細胞リンパ腫治療を目的とした全身投与型組換えヒトDNaseの臨床試験で最初の参加者に投与したと発表
上昇銘柄ヘルスケア株
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
 INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
 HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
 TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
下落銘柄ヘルスケア株
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
 PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |